Objective
The overall objective will be to create and mobilise an International network of high calibre centres around a strong European group of institutes selected for their appropriate expertises, to collect, amplify, characterise, standardise, authenticate, distribute and track, mammalian and other exotic viruses. The network of EVAg laboratories including 25 institutions represents an extensive range of virological disciplines. The architecture of the consortium is based on the association of capacities accessible to the partners but also to any end-users through the EVAg web-based catalogue. This concept has been elaborated and tested for its efficiency during the successful EVA project (FP7). The project will integrate more facilities dedicated to high risk pathogen (HRP) manipulation (1 in EVA, 13 in EVAg) The access to products derived from those HRP will be enhanced and for instance the production of diagnostic reagents will be facilitated. The new project will also provide access to high containment biosafety facilities to carry out in vivo studies of infectious disease using natural or models hosts, to look at prophylactic or therapeutic control measures and to develop materials for the evaluation of diagnostic tests, meaning an extensive capacity to service and to training. EVAg will also link up with other network-based virus-associated programmes that exist globally. However, looking further ahead, EVAg is conceived ultimately to be an open entity aiming at developing synergies and complementarity capabilities in such a way as to offer an improved access to researchers. This project will generate the largest collection of mammalian viruses in the world and move beyond the current state-of-the-art to provide an increasingly valuable resource and service to the world’s scientific community, including government health departments, higher education institutes, industry and, through information systems, the general public.
Fields of science
Not validated
Not validated
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
13284 Marseille
France
See on map
Participants (27)
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
13572 Marseille
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
75794 Paris
See on map
20359 Hamburg
See on map
SW1P 4DF LONDON
See on map
Participation ended
53127 Bonn
See on map
LS2 7UE Leeds
See on map
4051 Basel
See on map
1000 Ljubljana
See on map
845 05 Bratislava
See on map
00149 Roma
See on map
13353 Berlin
See on map
3015 GD Rotterdam
See on map
2333 ZA Leiden
See on map
75654 Paris
See on map
75724 Paris
See on map
17493 Greifswald-Insel Riems
See on map
GU24 0NF Woking
See on map
0001 Pretoria
See on map
2131 Sandringham
See on map
142782 MOSKVA
See on map
197376 ST PETERSBURG
See on map
105064 Moscow
See on map
430071 WUHAN
See on map
2601 Acton Act
See on map
171 82 Solna
See on map
69227 Lyon
See on map
10117 Berlin
See on map